These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31438)

  • 41. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

  • 42. Interactions of various drugs with amphetamine.
    Garattini S; Jori A; Samanin R
    Ann N Y Acad Sci; 1976; 281():409-25. PubMed ID: 798529
    [No Abstract]   [Full Text] [Related]  

  • 43. Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine.
    Glick SD; Gallagher CA; Hough LB; Rossman KL; Maisonneuve IM
    Brain Res; 1992 Aug; 588(1):173-6. PubMed ID: 1393568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antileptazol activity and kinetics of clobazam and N-desmethyl-clobazam in the guinea-pig.
    Ballabio M; Caccia S; Garattini S; Guiso G; Zanini MG
    Arch Int Pharmacodyn Ther; 1981 Oct; 253(2):192-9. PubMed ID: 7325759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Blood-brain barrier: I. Kinetics of the distribution of amphetamine H3-in brain structures of the rate after intravenous administration].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):337-47. PubMed ID: 4614730
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of chronic intoxication with (+)-amphetamine on its concentration in liver and brain and on (14C) leucine incorporation into microsomal and cytoplasmic proteins of rat liver.
    Magour S; Coper H; Fähndrich C
    J Pharm Pharmacol; 1974 Feb; 26(2):105-8. PubMed ID: 4150824
    [No Abstract]   [Full Text] [Related]  

  • 47. Brain monoamines are involved in the sedative effects of opiates and neuroleptics.
    Furst S
    Prog Clin Biol Res; 1990; 328():311-4. PubMed ID: 1968267
    [No Abstract]   [Full Text] [Related]  

  • 48. The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions.
    Kennedy LA; Zigmond MJ
    Brain Res; 1979 May; 168(2):408-13. PubMed ID: 221074
    [No Abstract]   [Full Text] [Related]  

  • 49. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
    Magour S; Coper H; Fähndrich C
    Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.
    Scatton B
    Adv Biochem Psychopharmacol; 1980; 24():31-6. PubMed ID: 6105783
    [No Abstract]   [Full Text] [Related]  

  • 51. Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration.
    Liederer BM; Phan KT; Ouyang H; Borchardt RT
    J Pharm Sci; 2005 Dec; 94(12):2676-87. PubMed ID: 16258984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on pharmacokinetics of 9 -fluorohydrocortisone in the rat, guinea pig and dog].
    Wenzl H; Garbe A; Nowak H
    Arzneimittelforschung; 1971 Aug; 21(8):Suppl:1115-22. PubMed ID: 5109326
    [No Abstract]   [Full Text] [Related]  

  • 53. Atypical neuroleptics stimulate neurogenesis in adult rat brain.
    Wakade CG; Mahadik SP; Waller JL; Chiu FC
    J Neurosci Res; 2002 Jul; 69(1):72-9. PubMed ID: 12111817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropharmacological supersensitivity-clinical and experimental correlates and methodological considerations.
    Owen RT
    Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):89-95. PubMed ID: 6121962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of [3H](+)-amphetamine binding sites in the rat central nervous system.
    Hauger RL; Hulihan-Giblin B; Skolnick P; Paul SM
    Life Sci; 1984 Feb; 34(8):771-82. PubMed ID: 6700378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat.
    Gruber SH; Nomikos GG; Mathé AA
    Neuropsychopharmacology; 2002 May; 26(5):595-604. PubMed ID: 11927184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amphetamine stimulation of glutaminase is blocked by neuroleptics.
    Sherman AD; Mott J
    Life Sci; 1985 Mar; 36(12):1163-7. PubMed ID: 2580205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The antagonism of adrenergic neurone blockade by amphetamine and dexamphetamine in the rat and guinea-pig.
    Follenfant MJ; Robson RD
    Br J Pharmacol; 1970 Apr; 38(4):792-801. PubMed ID: 5441791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The conversion in vivo of D-amphetamine to (+)-p-hydroxynorephedrine.
    Goldstein M; Anagnoste B
    Biochim Biophys Acta; 1965 Aug; 107(1):166-8. PubMed ID: 5857361
    [No Abstract]   [Full Text] [Related]  

  • 60. Interconversions of haloperidol and reduced haloperidol in guinea pig and rat liver microsomes.
    Korpi ER; Costakos DT; Wyatt RJ
    Biochem Pharmacol; 1985 Aug; 34(16):2923-7. PubMed ID: 4026878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.